Source: BioPortfolio

Juvaris BioTherapeutics: Juvaris BioTherapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250

SummaryJuvaris BioTherapeutics Inc Juvaris is a pharmaceutical company that develops adjuvanted vaccines and immunotherapeutics to treat cancer and infectious disease in the fields of human and animal health. The company's lead product candidiate JVRS100 a...

Read full article »
Juvaris BioTherapeutics's Competitors | Juvaris BioTherapeutics's News | Juvaris BioTherapeutics's Financials
Stay up-to-date with the latest news on Juvaris BioTherapeutics
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Grant E. Pickering's photo - President & CEO of Juvaris BioTherapeutics

President & CEO

Grant E. Pickering

CEO Approval Rating

68/100

Read more
Stay up-to-date with the latest news on Juvaris BioTherapeutics